Beijing Luzhu Biotechnology Co., Ltd. (HKG:2480)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
19.42
-0.06 (-0.31%)
Last updated: May 27, 2026, 10:19 AM HKT
Market Cap3.86B -11.9%
Revenue (ttm)n/a
Net Income-167.32M
EPS-0.84
Shares Out 198.91M
PE Ration/a
Forward PE33.61
Dividendn/a
Ex-Dividend Daten/a
Volume200
Open19.45
Previous Close19.48
Day's Range19.42 - 19.45
52-Week Range19.42 - 28.00
Beta-0.69
Analystsn/a
Price Targetn/a
Earnings DateJun 2, 2026

About HKG:2480

Beijing Luzhu Biotechnology Co., Ltd., a biotechnology company, focuses on the research and development, production, and sale of human vaccines and therapeutic biologics to prevent and control infectious diseases, and treat cancer and autoimmune diseases in Mainland China. Its clinical-stage product candidates include LZ901, a recombinant herpes zoster vaccine, which completed Phase III clinical trial; K3, a recombinant human anti-tumor necrosis factor-alpha monoclonal antibody injection product for the treatment of autoimmune diseases, such as... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Employees 193
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2480
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements